Literature DB >> 27271547

Carotenoid intake and adipose tissue carotenoid levels in relation to prostate cancer aggressiveness among African-American and European-American men in the North Carolina-Louisiana prostate cancer project (PCaP).

Samuel O Antwi1, Susan E Steck2,3, L Joseph Su4, James R Hebert2,3, Hongmei Zhang5, Neal E Craft6, Elizabeth T H Fontham7, Gary J Smith8, Jeannette T Bensen9, James L Mohler8, Lenore Arab10.   

Abstract

BACKGROUND: Associations between carotenoid intake and prostate cancer (CaP) incidence have varied across studies. This may result from combining indolent with aggressive disease in most studies. This study examined whether carotenoid intake and adipose tissue carotenoid levels were inversely associated with CaP aggressiveness.
METHODS: Data on African-American (AA, n = 1,023) and European-American (EA, n = 1,079) men with incident CaP from North Carolina and Louisiana were analyzed. Dietary carotenoid intake was assessed using a detailed-food frequency questionnaire (FFQ), and abdominal adipose tissue samples were analyzed for carotenoid concentrations using high-performance liquid chromatography. Multivariable logistic regression was used in race-stratified analyses to calculate odds ratios (ORs) and 95% confidence intervals (95%CI) comparing high aggressive CaP with low/intermediate aggressive CaP.
RESULTS: Carotenoid intake differed significantly between AAs and EAs, which included higher intake of lycopene among EAs and higher β-cryptoxanthin intake among AAs. Comparing the highest and lowest tertiles, dietary lycopene was associated inversely with high aggressive CaP among EAs (OR = 0.55, 95%CI: 0.34-0.89, Ptrend  = 0.02), while an inverse association was observed between dietary β-cryptoxanthin intake and high aggressive CaP among AAs (OR = 0.56, 95%CI: 0.36-0.87, Ptrend  = 0.01). Adipose tissue α-carotene and lycopene (cis + trans) concentrations were higher among EAs than AAs, and marginally significant inverse linear trends were observed for adipose α-carotene (Ptrend  = 0.07) and lycopene (Ptrend  = 0.11), and CaP aggressiveness among EAs only.
CONCLUSIONS: These results suggest that diets high in lycopene and β-cryptoxanthin may protect against aggressive CaP among EAs and AAs, respectively. Differences in dietary behaviors may explain the observed racial differences in associations. Prostate 76:1053-1066, 2016.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  adipose tissue; carotenoids; lutein; lycopene; nutritional biomarkers; prostate cancer; supplements; zeaxanthin; α−carotene; β−carotene; β−cryptoxanthin

Mesh:

Substances:

Year:  2016        PMID: 27271547      PMCID: PMC5080909          DOI: 10.1002/pros.23189

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  48 in total

1.  Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.

Authors:  P H Gann; J Ma; E Giovannucci; W Willett; F M Sacks; C H Hennekens; M J Stampfer
Journal:  Cancer Res       Date:  1999-03-15       Impact factor: 12.701

Review 2.  Role of diet in prostate cancer development and progression.

Authors:  June M Chan; Peter H Gann; Edward L Giovannucci
Journal:  J Clin Oncol       Date:  2005-11-10       Impact factor: 44.544

3.  Relationship between plasma carotenoids and prostate cancer.

Authors:  Shine Chang; John W Erdman; Steven K Clinton; Maya Vadiveloo; Sara S Strom; Yuko Yamamura; Cherie M Duphorne; Margaret R Spitz; Christopher I Amos; John H Contois; Xiangjun Gu; Richard J Babaian; Peter T Scardino; Stephen D Hursting
Journal:  Nutr Cancer       Date:  2005       Impact factor: 2.900

Review 4.  Cruciferous vegetables intake and risk of prostate cancer: a meta-analysis.

Authors:  Ben Liu; Qiqi Mao; Min Cao; Liping Xie
Journal:  Int J Urol       Date:  2011-11-28       Impact factor: 3.369

5.  Dietary supplement use and prostate cancer risk in the Carotene and Retinol Efficacy Trial.

Authors:  Marian L Neuhouser; Matt J Barnett; Alan R Kristal; Christine B Ambrosone; Irena B King; Mark Thornquist; Gary G Goodman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-08       Impact factor: 4.254

Review 6.  Dietary antioxidants and prostate cancer: a review.

Authors:  Terrence M Vance; Joseph Su; Elizabeth T H Fontham; Sung I Koo; Ock K Chun
Journal:  Nutr Cancer       Date:  2013       Impact factor: 2.900

7.  Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial.

Authors:  Alan R Kristal; Kathryn B Arnold; Marian L Neuhouser; Phyllis Goodman; Elizabeth A Platz; Demetrius Albanes; Ian M Thompson
Journal:  Am J Epidemiol       Date:  2010-08-06       Impact factor: 4.897

8.  Do dietary lycopene and other carotenoids protect against prostate cancer?

Authors:  Le Jian; Chuan-Jun Du; Andy H Lee; Colin W Binns
Journal:  Int J Cancer       Date:  2005-03-01       Impact factor: 7.396

9.  Intake of carotenoids and retinol in relation to risk of prostate cancer.

Authors:  E Giovannucci; A Ascherio; E B Rimm; M J Stampfer; G A Colditz; W C Willett
Journal:  J Natl Cancer Inst       Date:  1995-12-06       Impact factor: 13.506

10.  Lycopene: a novel drug therapy in hormone refractory metastatic prostate cancer.

Authors:  M S Ansari; N P Gupta
Journal:  Urol Oncol       Date:  2004 Sep-Oct       Impact factor: 3.498

View more
  7 in total

Review 1.  Increased dietary and circulating lycopene are associated with reduced prostate cancer risk: a systematic review and meta-analysis.

Authors:  J L Rowles; K M Ranard; J W Smith; R An; J W Erdman
Journal:  Prostate Cancer Prostatic Dis       Date:  2017-04-25       Impact factor: 5.554

Review 2.  Can Diet Prevent Urological Cancers? An Update on Carotenoids as Chemopreventive Agents.

Authors:  Tomasz Konecki; Aleksandra Juszczak; Marcin Cichocki
Journal:  Nutrients       Date:  2022-03-25       Impact factor: 5.717

3.  Dietary Carotenoid Intakes and Prostate Cancer Risk: A Case-Control Study from Vietnam.

Authors:  Dong Van Hoang; Ngoc Minh Pham; Andy H Lee; Duong Nhu Tran; Colin W Binns
Journal:  Nutrients       Date:  2018-01-11       Impact factor: 5.717

Review 4.  Nutraceuticals in prostate cancer therapeutic strategies and their neo-adjuvant use in diverse populations.

Authors:  Dominique Reed; Komal Raina; Rajesh Agarwal
Journal:  NPJ Precis Oncol       Date:  2018-07-25

Review 5.  Chili Pepper Carotenoids: Nutraceutical Properties and Mechanisms of Action.

Authors:  Maria Guadalupe Villa-Rivera; Neftalí Ochoa-Alejo
Journal:  Molecules       Date:  2020-11-27       Impact factor: 4.411

6.  Insufficient Lycopene Intake Is Associated With High Risk of Prostate Cancer: A Cross-Sectional Study From the National Health and Nutrition Examination Survey (2003-2010).

Authors:  You Lu; Andrea Edwards; Zhong Chen; Tung-Sung Tseng; Mirandy Li; Gabrielle V Gonzalez; Kun Zhang
Journal:  Front Public Health       Date:  2021-12-13

7.  Associations of Subtype and Isomeric Plasma Carotenoids with Prostate Cancer Risk in Low-Income African and European Americans.

Authors:  Sang-Ah Lee; Qiuyin Cai; Adrian A Franke; Mark Steinwandel; Jie Wu; Wanqing Wen; Wei Zheng; William J Blot; Xiao-Ou Shu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-07-16       Impact factor: 4.254

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.